Glycogen synthase kinase-3 regulates production of amyloid- β peptides and tau phosphorylation in diabetic rat brain

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Qu, Zhong Sen ^a   Li, Liang ^b   Sun, Xiao Jiang ^a   Zhao, Yu Wu ^a   Zhang, Jin ^a   Geng, Zhi ^a   Fu, Jian Liang ^a   Ren, Qing Guo ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; PROTEIN KINASE B; STREPTOZOCIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME REGULATION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOREACTIVITY; LATENT PERIOD; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; ENZYME ACTIVATION; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHOSPHORYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TAU PROTEINS;

EID: 84899418713     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/878123     Document Type: Article

References (29)

1. Selkoe D. J., The cell biology β -amyloid precursor protein and presenilin in Alzheimer's disease. Trends in Cell Biology 1998 8 11 447 453 2-s2.0-0032211830 10.1016/S0962-8924(98)01363-4
2. Grundke-Iqbal I., Iqbal K., Tung Y.-C., Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences of the United States of America 1986 83 13 44913 4917 2-s2.0-0022744803
3. Phiel C. J., Wilson C. A., Lee V. M.-Y., Klein P. S., GSK-3 α regulates production of Alzheimer's disease amyloid- β peptides. Nature 2003 423 6938 435 438 2-s2.0-0038187674 10.1038/nature01640
4. Shi J. L., Jia Y. Z., Hong L. L., Zheng Y. F., Wang Q., Heng M. D., Cheng X. G., Grundke-Iqbal I., Iqbal K., Jian Z. W., Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. The Journal of Biological Chemistry 2004 279 48 50078 50088 2-s2.0-9644257211 10.1074/jbc.M406109200
5. Salkovic-Petrisic M., Tribl F., Schmidt M., Hoyer S., Riederer P., Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. Journal of Neurochemistry 2006 96 4 1005 1015 2-s2.0-33645100144 10.1111/j.1471-4159.2005.03637.x
6. Xu W. L., Qiu C. X., Wahlin Å., Winblad B., Fratiglioni L., Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004 63 7 1181 1186 2-s2.0-5344237420
7. Ott A., Stolk R. P., van Harskamp F., Pols H. A., Hofman A., Breteler M. M., Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999 53 9 1937 1942 2-s2.0-0032764016
8. Nicolls M. R., The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease. Current Alzheimer Research 2004 1 1 47 54 2-s2.0-23044442730
9. Shuli S., Yongmei Z., Zhijuan Z., Zhiwei J., β -Amyloid and its binding protein in the hippocampus of diabetic mice: effect of APP17 peptide. NeuroReport 2001 12 15 3317 3319 2-s2.0-0035968863
10. Ho L., Qin W., Pompl P. N., Xiang Z., Wang J., Zhao Z., Peng Y., Cambareri G., Rocher A., Mobbs C. V., Hof P. R., Pasinetti G. M., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. The FASEB Journal 2004 18 7 902 904 2-s2.0-4644286910
11. Kaidanovich O., Eldar-Finkelman H., The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes. Expert Opinion on Therapeutic Targets 2002 6 5 555 561 2-s2.0-0036398986 10.1517/14728222.6.5.555
12. Eldar-Finkelman H., Schreyer S. A., Shinohara M. M., LeBoeuf R. C., Krebs E. G., Increased glycogen synthase kinase-3 activity in diabetes- and obesity- prone C57BL/6J mice. Diabetes 1999 48 8 1662 1666 2-s2.0-0032802629 10.2337/diabetes.48.8.1662
13. Zhao Y.-M., Pei J.-J., Ji Z.-J., Zhao Z.-W., Qian Y.-Y., Sheng S.-L., Effect of amyloid precursor protein 17mer peptide on microtubule structure and tau protein hyperphosphorylation in hippocampal neurons of experimental diabetic mice. NeuroReport 2003 14 1 61 66 2-s2.0-0037454953 10.1097/00001756-200301200- 00012
14. Schechter R., Beju D., Miller K. E., The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochemical and Biophysical Research Communications 2005 334 4 979 986 2-s2.0-23044481208 10.1016/j.bbrc.2005.07.001
15. Stambolic V., Ruel L., Woodgett J. R., Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology 1996 6 12 1664 1668 2-s2.0-0030449964
16. Tanaka T., Zhong J., Iqbal K., Trenkner E., Grundke-Iqbal I., The regulation of phosphorylation of τ in SY5Y neuroblastoma cells: the role of protein phosphatases. The FEBS Letters 1998 426 2 248 254 2-s2.0-0032540459 10.1016/S0014-5793(98)00346-9
17. Jacob A., Cooney D., Tridandapani S., Kelley T., Coggeshall K. M., Fc γ RIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. The Journal of Biological Chemistry 1999 274 19 13704 13710 2-s2.0-0033531796 10.1074/jbc.274.19.13704
18. Clodfelder-Miller B., de Sarno P., Zmijewska A. A., Song L., Jope R. S., Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. The Journal of Biological Chemistry 2005 280 48 39723 39731 2-s2.0-28844493414 10.1074/jbc.M508824200
19. Zhang Y.-C., Wang Z.-F., Wang Q., Wang Y.-P., Wang J.-Z., Melatonin attenuates β -amyloid-induced inhibition of neurofilament expression. Acta Pharmacologica Sinica 2004 25 4 447 451 2-s2.0-1842759592
20. Bennecib M., Gong C.-X., Grundke-Iqbal I., Iqbal K., Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. The FEBS Letters 2000 485 1 87 93 2-s2.0-0034680902 10.1016/S0014-5793(00)02203-1
21. Mooradian A. D., Pathophysiology of central nervous system complications in diabetes mellitus. Clinical Neuroscience 1997 4 6 322 326 2-s2.0-0030687601
22. Biessels G. J., van der Heide L. P., Kamal A., Bleys R. L. A. W., Gispen W. H., Ageing and diabetes: implications for brain function. European Journal of Pharmacology 2002 441 1-2 1 14 2-s2.0-0037134269 10.1016/S0014-2999(02)01486-3
23. Muñoz-Montaño J. R., Moreno F. J., Avila J., Díaz-Nido J., Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Letters 1997 411 2-3 183 188 2-s2.0-0031567583 10.1016/S0014-5793(97)00688-1
24. Hong M., Chen D. C. R., Klein P. S., Lee V. M.-Y., Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. The Journal of Biological Chemistry 1997 272 40 25326 25332 2-s2.0-0030868557 10.1074/jbc.272.40.25326
25. Tomidokoro Y., Ishiguro K., Harigaya Y., Matsubara E., Ikeda M., Park J.-M., Yasutake K., Kawarabayashi T., Okamoto K., Shoji M., A β amyloidosis induces the initial stage of tau accumulation in APPSw mice. Neuroscience Letters 2001 299 3 169 172 2-s2.0-0035936683 10.1016/S0304-3940(00)01767-5
26. Li T., Paudel H. K., Glycogen synthase kinase 3 β phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 2006 45 10 3125 3133 2-s2.0-33644870413 10.1021/bi051634r
27. Chen Y.-G., Specific tau phosphorylation sites in hippocampus correlate with impairment of step-down inhibitory avoidance task in rats. Behavioural Brain Research 2005 158 2 277 284 2-s2.0-13444309165 10.1016/j.bbr.2004.09.007
28. Le Freche H., Brouillette J., Fernandez-Gomez F.-J., Patin P., Caillierez R., Zommer N., Sergeant N., Buée-Scherrer V., Lebuffe G., Blum D., Buée L., Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology 2012 116 4 779 787 2-s2.0-84859100613 10.1097/ALN.0b013e31824be8c7
29. Moosavi M., Yadollahi Khales G., Abbasi L., Zarifkar A., Rastegar K., Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation. Neuropharmacology 2012 62 5-6 2018 2023 2-s2.0-84857039173 10.1016/j.neuropharm.2011.12.031